Disclosure of confidential business information

Disclosure of confidential business information This guidance document describes how we disclose confidential business information (CBI) under paragraph 21.1(3)(c) of the Food and Drugs Act. 2021-06-02 Health Canada open-ouvert@tbs-sct.gc.ca Health and Safetyrequest for disclosureconfidential business informationCBIdisclosure of confidential business information Disclosure of confidential business informationHTML https://www.canada.ca/en/health-canada/services/drug-health-product-review-approval/request-disclosure-confidential-business-information/disclosure-confidential-business-information.html Disclosure of confidential business informationHTML https://www.canada.ca/fr/sante-canada/services/examen-et-approbation-medicaments-et-produit-sante/requete-renseignements-commerciaux-confidentiels/communication-renseignements-commerciaux-confidentiels.html

This guidance document describes how we disclose confidential business information (CBI) under paragraph 21.1(3)(c) of the Food and Drugs Act.

Data and Resources

Similar records